Skip to main content

Summary

What it measures:

The Multiple Sclerosis Functional Composite uses a combination of tests to measures 3 components of function.1

  • Leg function/ambulation via Timed 25 Foot Walk (T25FW)
  • Arm/hand function via 9‐Hole Peg Test (9HPT)
  • Cognitive function via Paced Auditory Serial Addition Test (PASAT-3)

Target Population:

Patients with multiple sclerosis (MS)

Task Force Recommendations

In 2012, the Academy of Neurologic Physical Therapy's Multiple Sclerosis Evaluation Database to Guide Effectiveness (MS-EDGE) taskforce made the following recommendations:

  1. MSFC is highly recommended for use in outpatient rehabilitation settings.
  2. MSFC is recommended for use in inpatient rehabilitation, skilled nursing facilities, and home health settings.
  3. MSFC is not recommended for use in acute care settings.

Clinical Insights:

This clinical tool was designed to be a multidimensional assessment tool to assist in determining current clinical disability status and to track overall progression of MS over time. The PASAT component of the MSFC has some limitations related to reliability due to possible practice effects.2 Despite these limitations, the MSFC continues to be a routinely used tool that is recommended as a method of assessing clinical disability status both in the clinic and when performing research.


You Might Also Like...

Clinical Summary

Parkinson Disease (PD)

Jun 25, 2024

People with PD need to develop long-term exercise habits—and be committed to participating in their intervention programs—to sustain the benefits of the

CPG

American College of Chest Physicians and Canadian Thoracic Society Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

Mar 27, 2023

This guideline was created by the American College of Chest Physicians and Canadian Thoracic Society to help clinicians and patients gauge the appropriate

CPG

Multiple Sclerosis in Adults: Management [NICE NG220]

Jun 22, 2022

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple